Macular cystoid spaces in patients with retinal dystrophy

References

• Ganesh A, Stroh E, Manayath GJ, et al. Macular cysts in retinal dystrophy. Curr Opin Ophthalmol 2011;22:332–339.
   PubMed Web of Science ®Google Scholar
• Fishman GA, Anderson RJ, Lam BL, et al. Prevalence of foveal lesions in type 1 and type 2 Usher’s syndrome. Arch Ophthalmol 1995;113:770–773.
   PubMedGoogle Scholar
• Genead MA, Fishman GA. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome. Arch Ophthalmol 2010;128:1146–1150.
   PubMed Web of Science ®Google Scholar
• Walia S, Fishman GA, Hajali M. Prevalence of cystic macular lesions in patients with Usher II syndrome. Eye (Lond) 2009;23:1206–1209.
   PubMed Web of Science ®Google Scholar
• Genead MA, Fishman GA, McAnany JJ. Efficacy of topical dorzolamide for treatment of cystic macular lesions in a patient with enhanced S-cone syndrome. Doc Ophthalmol 2010;121:231–240.
   PubMed Web of Science ®Google Scholar
• Ghajarnia M, Gorin MB. Acetazolamide in the treatment of X-linked retinoschisis maculopathy. Arch Ophthalmol 2007;125:571–573.
   PubMed Web of Science ®Google Scholar
• Apushkin MA, Fishman GA. Use of dorzolamide for patients with X-linked retinoschisis. Retina 2006;26:741–745.
   PubMed Web of Science ®Google Scholar
• Walia S, Fishman GA, Molday RS, et al. Relation of response to treatment with dorzolamide in X-linked retinoschisis to the mechanism of functional loss in retinoschisin. Am J Ophthalmol 2009;147:111–115 e1.
   PubMed Web of Science ®Google Scholar
• Yang FP, Willyasti K, Leo SW. Topical brinzolamide for foveal schisis in juvenile retinoschisis. J AAPOS 2013;17:225–227.
   PubMed Web of Science ®Google Scholar
• Salvatore S, Fishman GA, Genead MA. Treatment of cystic macular lesions in hereditary retinal dystrophies. Surv Ophthalmol 2013;58:560–584.
   PubMed Web of Science ®Google Scholar
• Hirakawa H, Iijima H, Gohdo T, et al. Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa. Am J Ophthalmol 1999;128:185–191.
   PubMed Web of Science ®Google Scholar
• Apushkin MA, Fishman GA, Janowicz MJ. Monitoring cystoid macular edema by optical coherence tomography in patients with retinitis pigmentosa. Ophthalmology 2004;111:1899–1904.
   PubMed Web of Science ®Google Scholar
• Lithander J. Visual development in healthy eyes from 24 months to four years of age. Acta Ophthalmol Scand 1997;75:275–276.
   PubMedGoogle Scholar
• Genead MA, Fishman GA, Walia S. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis. Arch Ophthalmol 2010;128:190–197.
   PubMed Web of Science ®Google Scholar
• Gass JD. Muller cell cone, an overlooked part of the anatomy of the fovea centralis: hypotheses concerning its role in the pathogenesis of macular hole and foveomacular retinoschisis. Arch Ophthalmol 1999;117:821–823.
   PubMed Web of Science ®Google Scholar
• Newsome DA. Retinal fluorescein leakage in retinitis pigmentosa. Am J Ophthalmol 1986;101:354–360.
   PubMed Web of Science ®Google Scholar
• Cox SN, Hay E, Bird AC. Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol 1988;106:1190–1195.
   PubMed Web of Science ®Google Scholar
• Spalton DJ, Rahi AH, Bird AC. Immunological studies in retinitis pigmentosa associated with retinal vascular leakage. Br J Ophthalmol 1978;62:183–187.
   PubMed Web of Science ®Google Scholar
• Hajali M, Fishman GA. The prevalence of cystoid macular oedema on optical coherence tomography in retinitis pigmentosa patients without cystic changes on fundus examination. Eye (Lond) 2009;23:915–919.
   PubMed Web of Science ®Google Scholar
• Jacobson SG, Cideciyan AV, Sumaroka A, et al. Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations. Invest Ophthalmol Vis Sci 2006;47:4113–4120.
   PubMed Web of Science ®Google Scholar
• Strunnikova NV, Barb J, Sergeev YV, et al. Loss-of-function mutations in Rab escort protein 1 (REP-1) affect intracellular transport in fibroblasts and monocytes of choroideremia patients. PloS One 2009;4:e8402.
   PubMed Web of Science ®Google Scholar
• Rossi E, Siwiec F, Yan CY. Pattern of Wnt ligand expression during chick eye development. Braz J Med Biol Res 2007;40:1333–1338.
   PubMed Web of Science ®Google Scholar
• Kashef J, Diana T, Oelgeschlager M, et al. Expression of the tetraspanin family members Tspan3, Tspan4, Tspan5 and Tspan7 during Xenopus laevis embryonic development. Gene Expr Patterns 2013;13:1–11.
   PubMed Web of Science ®Google Scholar
• Sohn EH, Chen FK, Rubin GS, et al. Macular function assessed by microperimetry in patients with enhanced S-cone syndrome. Ophthalmology 2010;117:1199–206 e1.
   PubMed Web of Science ®Google Scholar
• Genead MA, Fishman GA. Cystic macular oedema on spectral-domain optical coherence tomography in choroideremia patients without cystic changes on fundus examination. Eye (Lond) 2011;25:84–90.
   PubMed Web of Science ®Google Scholar
• Sauer CG, Gehrig A, Warneke-Wittstock R, et al. Positional cloning of the gene associated with X-linked juvenile retinoschisis. Nat Genet 1997;17:164–170.
   PubMed Web of Science ®Google Scholar
• Tepass U, Theres C, Knust E. crumbs encodes an EGF-like protein expressed on apical membranes of Drosophila epithelial cells and required for organization of epithelia. Cell 1990;61:787–799.
   PubMed Web of Science ®Google Scholar
• Cordovez JA, Traboulsi EI, Capasso JE, et al. Retinal dystrophy with intraretinal cystoid spaces associated with mutations in the crumbs homologue (CRB1) gene. Ophthalmic Genet 2015;36:257–64.
   PubMed Web of Science ®Google Scholar
• Schwartz SB, Aleman TS, Cideciyan AV, et al. Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotype. Invest Ophthalmol Vis Sci 2005;46:734–743.
   PubMed Web of Science ®Google Scholar
• McMillan DR, Kayes-Wandover KM, Richardson JA, et al. Very large G protein-coupled receptor-1, the largest known cell surface protein, is highly expressed in the developing central nervous system. J Biol Chem 2002;277:785–792.
   PubMed Web of Science ®Google Scholar
• Eudy JD, Weston MD, Yao S, et al. Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science 1998;280:1753–1757.
   PubMed Web of Science ®Google Scholar
• Weston MD, Eudy JD, Fujita S, et al. Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet 2000;66:1199–1210.
   PubMed Web of Science ®Google Scholar
• Wistrand PJ, Schenholm M, Lonnerholm G. Carbonic anhydrase isoenzymes CA I and CA II in the human eye. Invest Ophthalmol Vis Sci 1986;27:419–428.
   PubMed Web of Science ®Google Scholar
• Marmor MF, Maack T. Enhancement of retinal adhesion and subretinal fluid resorption by acetazolamide. Invest Ophthalmol Vis Sci 1982;23:121–124.
   PubMed Web of Science ®Google Scholar
• Wolfensberger TJ, Dmitriev AV, Govardovskii VI. Inhibition of membrane-bound carbonic anhydrase decreases subretinal pH and volume. Doc Ophthalmol 1999;97:261–271.
   PubMed Web of Science ®Google Scholar
• Wilson TM, Strang R, MacKenzie ET. The response of the choroidal and cerebral circulations to changing arterial PCO2 and acetazolamide in the baboon. Invest Ophthalmol Vis Sci 1977;16:576–580.
   PubMed Web of Science ®Google Scholar
• Genead MA, McAnany JJ, Fishman GA. Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia. Retina 2012;32:826–833.
   PubMed Web of Science ®Google Scholar
• Grover S, Apushkin MA, Fishman GA. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 2006;141:850–858.
   PubMed Web of Science ®Google Scholar
• Thobani A, Fishman GA. The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis. Retina 2011;31:312–315.
   PubMed Web of Science ®Google Scholar
• Chen JC, Fitzke FW, Bird AC. Long-term effect of acetazolamide in a patient with retinitis pigmentosa. Invest Ophthalmol Vis Sci 1990;31:1914–1918.
   PubMed Web of Science ®Google Scholar
• Fishman GA, Gilbert LD, Fiscella RG, et al. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol 1989;107:1445–1452.
   PubMed Web of Science ®Google Scholar
• Ffytche TJ. Cystoid maculopathy in retinitis pigmentosa. Trans Ophthalmol Soc UK 1972;92:265–283.
   PubMedGoogle Scholar
• Nussenblatt RB, Kaufman SC, Palestine AG, et al. Macular thickening and visual acuity. Measurement in patients with cystoid macular edema. Ophthalmology 1987;94:1134–1139.
   Google Scholar
• Stanga PE, Downes SM, Ahuja RM, et al. Comparison of optical coherence tomography and fluorescein angiography in assessing macular edema in retinal dystrophies: preliminary results. Int Ophthalmol 2001;23:321–325.
   PubMedGoogle Scholar
• Gurbaxani A, Wei M, Succar T, et al. Acetazolamide in retinoschisis: a prospective study. Ophthalmology 2014;121:802–803 e3.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Joe SG, Lee DH, et al. Correlations between spectral-domain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa. Invest Ophthalmol Vis Sci 2013;54:1303–1309.
   PubMed Web of Science ®Google Scholar
• George ND, Yates JR, Moore AT. Clinical features in affected males with X-linked retinoschisis. Arch Ophthalmol 1996;114:274–280.
   PubMed Web of Science ®Google Scholar
• Roesch MT, Ewing CC, Gibson AE, et al. The natural history of X-linked retinoschisis. Can J Ophthalmol 1998;33:149–158.
   PubMed Web of Science ®Google Scholar
• Marmor MF. Hypothesis concerning carbonic anhydrase treatment of cystoid macular edema: example with epiretinal membrane. Arch Ophthalmol 1990;108:1524–1525.
   PubMedGoogle Scholar